OFIX

$10.34+$0.16 (+1.57%)live

Compare

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institution

Market cap

$423.6M

41M shares

52-week range

$8.85 – $16.99

18% from low

Sector

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

Exchange

NASDAQ

Change$-29.38

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$849M	+4.2%	$-1.17	$-1.19–$-1.15	—	1
2027	$877M	+3.3%	$-0.88	$-0.89–$-0.86	—	1
2028	$935M	+6.6%	$-0.34	$-0.59–$-0.08	—	2
2029	$1.0B	+7.4%	$0.00	$0.00–$0.00	—	0

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Earnings surprises

Beat consensus in 7 of the last 8 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-08-05	$-0.41	$-0.39	+4.9%
2026-05-05	$-0.68	$-0.52	+23.5%
2026-02-24	$-0.19	$-0.06	+70.8%
2025-11-04	$0.12	$0.20	+66.7%
2025-08-05	$0.04	$0.13	+225.0%
2025-05-06	$-0.17	$-0.08	+52.9%
2025-02-25	$0.06	$0.02	-66.7%
2024-11-07	$-0.14

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
OFIXOrthofix Medical Inc.	$10.34	+1.57%	$418M	—
ABSIAbsci Corporation	$9.18	-2.96%	$1.6B	—
AVNSAvanos Medical, Inc.	$24.99	+0.04%	$1.2B	—
BFLYButterfly Network, Inc.	$8.84	-0.23%	$2.4B	—
DRIODarioHealth Corp.	$7.58	+3.48%

Orthofix Medical Inc. Common Stock (DE)

Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.

www.orthofix.com

Employees: 1,605
IPO / List date: Apr 24, 1992
HQ: LEWISVILLE, TX

Held by traders on TradeandTell

No one on the platform currently holds OFIX.

Super investors & insiders

Institutions holding (13F)

Institution	Shares	Reported
Renaissance Technologiesas of 2026-03-31	101,991	$1.2M

Insider activity (SEC Form 4)

Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded OFIX yet.

$OFIX chatter on StockTwits

MarketBeat Earnings@EarningsInsiderAug 5
https://www.marketbeat.com/earnings/reports/2026-8-5-orthofix-medical-inc-stock/ $OFIX Orthofix Medical Earnings Transcript
View on StockTwits ↗
Stocktwits Earnings@StocktwitsEarningsAug 5
$OFIX Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.39 down -8.33% YoY • Reported revenue of $210.93M up 3.85% YoY
View on StockTwits ↗
Swingstocktraders@stockpicker63BullishJul 11
🚀 Weekly Results Are In Our system delivered again this week with strong performance. 🔥 Top Trades (+): $PENG +21% $OFIX +10,1% $BBOT +8.2% $TRAX +8.2% Correction: $IREN +3.7% Consistency. Discipline. Results. 📊 Full breakdown available on the website
View on StockTwits ↗
Top Stock Alerts@topstockalertsJul 6
$OFIX this just keeps pushing without much effort
View on StockTwits ↗
Warren Buffett 4 Less@DollarstorebuffettBullishJul 6
@St0ckmaster11 nice $OFIX call. May I ask what you drew you to this play? Vitl and brbr are much more justified by dcf, but I trust your judgement. I sold vitl for brbr, but keep tabs on it. What's your PT?
View on StockTwits ↗
Inner Child@InnerchildBullishJul 6
$VRXA All I see here is money money money $DGXX $WSHP $OFIX
View on StockTwits ↗
joe@St0ckmaster11BullishJul 6
$OFIX bought this under $9 less than a week ago and posted so others could also get a piece of this pie. I’m out with a 26% gain in less than a week. Will look to re-enter on any pullbacks. (Still holding VITL and BRBR!) $SPY $VITL $BRBR
View on StockTwits ↗
DonCorleone77@DonCorleone77Jul 6
$SEER $WULF $OFIX $AVGO PRE-MARKET MOVERS: Currently Higher: - Seer (SEER) up 37.7% after receiving an unsolicited, non-binding proposal from Omid Farokhzad, Seer's chair and CEO, to acquire all of the outstanding shares of Seer's Class A common stock for $2.45 per share in cash plus two separate contingent value rights - TeraWulf (WULF) up 15.8% after executing a 20-year lease agreement with Anthropic at its Justified Data campus in Hawesville, Kentucky - Orthofix (OFIX) up 7.3% after disclosing that CMS had reversed itself on its very recent 10% reimbursement cut within traditional Medicare for non-invasive bone growth stimulators - Broadcom (AVGO) up 3.6% after disclosing an agreement with Apple (AAPL) to expand their long-standing technology collaboration through 2031 by entering into new multi-year long-term agreements for Broadcom to develop and supply a range of custom ASIC silicon products for use in multiple generations of Apple products - Kosmos (KOS) up 1.9% after providing a portfolio update - Alibaba (BABA) up 0.7% after Bloomberg reported U.S. District Judge Eumi Lee has ordered the Pentagon to give Alibaba reprieve from a law that led to many lobbyists dropping it as a client while she considers the constitutionality of the measure Currently Lower: - Datadog (DDOG) down 4.7% after Bernstein downgraded the stock to Market Perform - J.B. Hunt (JBHT) down 1.4% after Morgan Stanley downgraded shares to Underweight
View on StockTwits ↗
Open Outcrier@OpenOutcrierJul 6
$OFIX (+8.0% pre) U.S. Food and Drug Administration (“FDA”) issued a final order reclassifying non-invasive bone growth stimulators from Class III to Class II devices https://ooc.bz/l/106901
View on StockTwits ↗
NOTRELOAD AI@notreload_aiJul 6
Medicare reversed a pay cut for $OFIX devices, restoring revenue outlook and boosting the stock on improved earnings visibility. https://notreload.xyz/xy/cms-reverses-medicare-reimbursement-changes-for-orthofix/
View on StockTwits ↗
Top Stock Alerts@topstockalertsJul 3
$OFIX the chart is starting to tell a story
View on StockTwits ↗
Mimi@mimiworBullishJul 2
$OFIX should go $15 on monday
View on StockTwits ↗
Mimi@mimiworBullishJul 2
$OFIX
View on StockTwits ↗
TradersLink@TradersLinkJul 2
$OFIX CMS withdraws May reimbursement changes; Medicare rates for non‑invasive bone growth stimulators expected to revert ORTHOFIX MEDICAL INC. filed SEC Form 8-K. Orthofix reported that after the FDA reclassified non‑invasive bone growth stimulators from Class III to Class II (Apr 16, 2026), CMS had changed billing and Medicare fee schedule treatment for HCPCS codes E0747, E0748 and E0760 effective May 18, 2026, but on July 1, 2026 CMS withdrew those changes and directed claims be processed consistent with pre‑May 18 treatment. The company currently expects average Medicare reimbursement for those codes to return to the rates in effect prior to May 18, 2026.
View on StockTwits ↗
AlertsAndNews@AlertsAndNewsJul 2
$OFIX form 8 here U.S. Food and Drug Administration (“FDA”) issued a final order reclassifying non-invasive bone growth stimulators from Class III to Class II devices.
View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.